相似文献
1
A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates.
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S368-71. doi: 10.1093/infdis/jiv019. Epub 2015 Mar 2.
2
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.00363-18. Print 2018 Jun 1.
3
Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection.
J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1060-5. doi: 10.1093/infdis/jir347.
4
Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
J Virol. 2017 May 12;91(11). doi: 10.1128/JVI.00343-17. Print 2017 Jun 1.
5
A Bivalent, Spherical Virus-Like Particle Vaccine Enhances Breadth of Immune Responses against Pathogenic Ebola Viruses in Rhesus Macaques.
J Virol. 2020 Apr 16;94(9). doi: 10.1128/JVI.01884-19.
6
An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates.
J Infect Dis. 2016 Oct 15;214(suppl 3):S326-S332. doi: 10.1093/infdis/jiw250. Epub 2016 Aug 4.
7
Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
Antiviral Res. 2016 Feb;126:55-61. doi: 10.1016/j.antiviral.2015.11.012. Epub 2015 Dec 8.
8
Evaluation in nonhuman primates of vaccines against Ebola virus.
Emerg Infect Dis. 2002 May;8(5):503-7. doi: 10.3201/eid0805.010284.
9
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
J Infect Dis. 2007 Nov 15;196 Suppl 2:S430-7. doi: 10.1086/520583.
10
Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus-Infected Nonhuman Primates.
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S379-83. doi: 10.1093/infdis/jiv102. Epub 2015 May 9.
引用本文的文献
1
Replicon RNA vaccines: design, delivery, and immunogenicity in infectious diseases and cancer.
J Hematol Oncol. 2025 Apr 17;18(1):43. doi: 10.1186/s13045-025-01694-2.
2
Tracing down the updates on Ebola virus surges: An update on anti-ebola therapeutic strategies.
J Transl Int Med. 2023 Sep 2;11(3):216-225. doi: 10.2478/jtim-2023-0100. eCollection 2023 Sep.
3
mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV.
Front Immunol. 2023 Apr 24;14:1172691. doi: 10.3389/fimmu.2023.1172691. eCollection 2023.
4
Replication-Deficient Zika Vector-Based Vaccine Provides Maternal and Fetal Protection in Mouse Model.
Microbiol Spectr. 2022 Oct 26;10(5):e0113722. doi: 10.1128/spectrum.01137-22. Epub 2022 Sep 28.
5
The Delivery of mRNA Vaccines for Therapeutics.
Life (Basel). 2022 Aug 17;12(8):1254. doi: 10.3390/life12081254.
6
A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses.
Vaccines (Basel). 2021 Dec 16;9(12):1492. doi: 10.3390/vaccines9121492.
7
Self-Replicating RNA Viruses for Vaccine Development against Infectious Diseases and Cancer.
Vaccines (Basel). 2021 Oct 15;9(10):1187. doi: 10.3390/vaccines9101187.
8
Development of a Multivalent Kunjin Virus Reporter Virus-Like Particle System Inducing Seroconversion for Ebola and West Nile Virus Proteins in Mice.
Microorganisms. 2020 Nov 29;8(12):1890. doi: 10.3390/microorganisms8121890.
9
Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19.
Viruses. 2020 Nov 18;12(11):1324. doi: 10.3390/v12111324.
10
Self-Amplifying RNA Viruses as RNA Vaccines.
Int J Mol Sci. 2020 Jul 20;21(14):5130. doi: 10.3390/ijms21145130.
本文引用的文献
1
Ebola vaccine--an urgent international priority.
N Engl J Med. 2014 Dec 11;371(24):2249-51. doi: 10.1056/NEJMp1412166. Epub 2014 Oct 7.
2
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge.
Nat Med. 2014 Oct;20(10):1126-9. doi: 10.1038/nm.3702. Epub 2014 Sep 7.
3
Ebola virus vaccines: an overview of current approaches.
Expert Rev Vaccines. 2014 Apr;13(4):521-31. doi: 10.1586/14760584.2014.885841. Epub 2014 Feb 27.
4
Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.
J Virol. 2013 May;87(9):4952-64. doi: 10.1128/JVI.03361-12. Epub 2013 Feb 13.
5
Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.
J Infect Dis. 2013 Jul 15;208(2):310-8. doi: 10.1093/infdis/jis921. Epub 2012 Dec 18.
6
Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1075-81. doi: 10.1093/infdis/jir349.
7
Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection.
J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1060-5. doi: 10.1093/infdis/jir347.
8
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
J Virol. 2009 Jul;83(14):7296-304. doi: 10.1128/JVI.00561-09. Epub 2009 Apr 22.
9
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates.
J Virol. 2008 Jun;82(11):5664-8. doi: 10.1128/JVI.00456-08. Epub 2008 Apr 2.
10
Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.
Expert Opin Biol Ther. 2006 Feb;6(2):135-45. doi: 10.1517/14712598.6.2.135.
Zotero 插件